BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that it has appointed Bonnie H. Anderson to serve on its board of directors, effective as of September 3, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200908005326/en/ (Photo: Business Wire) Ms. Anderson is Co-Founder, Chairman of the Board and CEO of Veracyte,... Read more
FBI Approves Thermo Fisher Scientific’s Rapid DNA Solution for National DNA Index System Applied Biosystems RapidHIT ID System plays key role in arrestee testing and investigative lead generation SOUTH SAN FRANCISCO, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems RapidHIT ID System for use... Read more
Immunocompromised transplant patients are at risk of major complications when infected with BK virus cobas BKV test addresses critical need for hospitals and laboratories to have standardised and comparable results across institutions New Breakthrough Device test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus... Read more
Hilden, 8. September 2020 – QIAGEN hat heute angekündigt, mehr als 110 Mio. Euro in den Ausbau seiner Kapazitäten für die Fertigung von COVID-19-Testprodukten an den Standorten Hilden, Germantown (Maryland, USA) und Barcelona zu investieren. Mit dem bislang größten Investitionsprogramm in der Unternehmensgeschichte setzt QIAGEN seine Anstrengungen fort, den globalen Kampf gegen die Pandemie durch die Erhöhung von... Read more
Gavreto is a once-daily, oral precision therapy that selectively inhibits RET-altered cancers Genentech and Blueprint Medicines will co-commercialise Gavreto in the United States FDA also granted Priority Review to Gavreto for the treatment of people with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer Basel, 7 September 2020 – Roche (SIX:... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 4, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Global Healthcare Conference 2020 on Wednesday, September 16, 2020 at 10:05 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview... Read more
First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample As COVID-19 and influenza infections can hardly be differentiated based on symptoms, healthcare professionals can confidently provide the right diagnosis and best course of treatment for patients Test for use... Read more
Researchers at Washington University in St. Louis find an easier way to quantify synaptic loci The brain’s vast synaptic network with billions of neurons making trillions of connections in a very dense matrix continues to challenge scientists who wish to decipher its intricacies in the context of brain health and disease. Established approaches using electron... Read more
CAMBRIDGE, Angleterre–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ : ILMN) a annoncé aujourd’hui une collaboration avec 54gene, une société de technologie de la santé dont la mission consiste à faire progresser les capacités de la médecine de précision en Afrique grâce à la recherche, des diagnostics moléculaires avancés et des programmes cliniques. Le partenariat permettra la création de nouvelles... Read more
CAMBRIDGE, Inglaterra–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) ha anunciado hoy una colaboración con 54gene, una empresa de tecnología sanitaria cuya misión es hacer avanzar las capacidades de la medicina de precisión en África a través de la investigación, los diagnósticos moleculares avanzados y los programas clínicos. La asociación ayudará a la creación de una nueva instalación... Read more